A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201–995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus
- 30 April 1991
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 30 (4) , 345-352
- https://doi.org/10.1016/0028-3908(91)90059-k
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Somatostatin in the central nervous system: Physiology and pathological modificationsPublished by Elsevier ,2003
- Role of the receptors in the development and maintenance of hippocampal kindling in ratsNeuroscience Letters, 1988
- Somatostatin Augments the M-Current in Hippocampal NeuronsScience, 1988
- Changes in immunoreactive somatostatin in brain following lidocaine-induced kindling in ratNeuropharmacology, 1984
- Seizures produced by pilocarpine in mice: A behavioral, electroencephalographic and morphological analysisBrain Research, 1984
- Changes of immunoreactive somatostatin and β-endorphin content in rat brain after amygdaloid kindlingLife Sciences, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- An EEG analysis of convulsive activity produced by cholinergic agentsProgress in Neuro-Psychopharmacology, 1981
- Is somatostatin an excitatory transmitter in the hippocampus?Nature, 1978
- Calcium-dependent release of somatostatin and neurotensin from rat brain in vitroNature, 1978